Despite their title-winning credentials, the 2025 semifinalists all have something to prove. Here's what to know with a spot ...
Data from Phase 3 Orbit and Cosmic studies of setrusumab in osteogenesis imperfecta on-track for around the end of 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback